Cite
HARVARD Citation
Wick, W. et al. (n.d.). KS05.6.A Oral DNA vaccination targeting VEGFR2 combined with the anti-PD-L1 antibody avelumab in patients with progressive glioblastoma - final results. NCT03750071. Neuro-oncology. p. ii6. [Online].